DARE
Dare Bioscience
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
DARE fundamentals
Dare Bioscience (DARE) expects to report earnings on Aug 11, 2025, with estimated revenue of 141.50K (YoY +530.63%), and EPS at -0.52 (YoY -134.21%).
Revenue estimate / YoY
141.50K
+530.63%
EPS estimate / YoY
-0.52
-134.21%
Report date
Aug 11, 2025
EPS
Revenue
Revenue & Expenses
DARE has released its 2025 Q1 earnings report, with revenue of 25.43K, reflecting a YoY change of 173.35%, and net profit of -4.38M, showing a YoY change of 35.19%. The Sankey diagram below clearly presents DARE's revenue sources and cost distribution.
Key Indicators
Dare Bioscience (DARE) key financial stats and ratios, covering profitability, financial health, and leverage.
Dare Bioscience (DARE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Dare Bioscience (DARE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Dare Bioscience (DARE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Dare Bioscience (DARE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Dare Bioscience (DARE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Dare Bioscience beat or miss consensus estimates last quarter?What is Dare Bioscience’s latest dividend and current dividend yield?What is the revenue and EPS growth rate for Dare Bioscience year over year?What does Dare Bioscience do and what are its main business segments?What is Dare Bioscience’s gross profit margin?How were Dare Bioscience’s latest financial results overall?What is the market’s earnings forecast for Dare Bioscience next quarter?What factors drove the changes in Dare Bioscience’s revenue and profit?